Sunshine Heart
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sunshine Heart - overview
Established
1999
Location
Eden Prairie, MN, US
Primary Industry
Medical Devices & Equipment
About
Sunshine Heart develops innovative medical technology solutions focused on treating heart failure and improving patient outcomes through advanced devices and therapies. Founded in 1999 and headquartered in Eden Prairie, US, Sunshine Heart specializes in medical technology aimed at treating heart conditions. The company went public in February 2012, listing on NASDAQ under the symbol SSH. Nestor Jaramillo is the CEO, overseeing the firm's strategy and operations.
Sunshine Heart has engaged in a total of six funding rounds, most recently raising USD 25. 00 mn through a PIPE round in February 2012, matching their total amount raised of USD 25. 00 mn. Sunshine Heart focuses on advanced medical devices designed specifically for heart failure treatment.
Their core offerings include innovative implantable devices that support patients with chronic heart conditions. The products are utilized in healthcare settings to improve patient management and treatment outcomes. The company caters to a global market, with a presence in North America, Europe, and selected regions in Asia, emphasizing the worldwide relevance of their medical technologies. In the most recent fiscal year of 2022, Sunshine Heart reported a revenue of USD 8.
54 mn. The company operates on a subscription-based model for its healthcare technologies, allowing hospitals and clinics to access their products through regular payments. This strategy fosters long-term relationships with healthcare providers while ensuring a stable revenue stream. The firm provides a range of products at various pricing tiers, accommodating the needs of different healthcare institutions.
Sunshine Heart is focused on expanding its product lineup with upcoming innovations planned for release in the next 12 months, enhancing its offerings for heart failure management. The company also plans to penetrate new markets in Asia and Europe by 2024, aiming to increase its global footprint. The funds raised from the recent PIPE round will support these expansions and product developments, facilitating further advancement in their medical technology initiatives.
Current Investors
Aspire Capital, GBS Venture Partners, CM Capital Investments
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.sunshineheart.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.